Press Center
NTP Study of the Hexavalent Chromium Compound Sodium Dichromate Dihydrate
Planned National Toxicology Program Studies of Hexavalent Chromium
Toxicity Evaluation Study Protocols
- 13-Week and 2-Year F344/N rat and B6C3F1 mouse studies
- 13-Week comparative BALB/C and AM3-C57Bl/6 mouse toxicity studies and, AM3-C57Bl/6 mouse mutagenesis studies
- Immunological Evaluation
Preliminary Results of the 13-Week F344 rat and B6C3F1 Mouse Studies
Preliminary Results of the comparative 13-week toxicity study of Sodium Dichromate Dihydrate in male BC3F1, BALB/C, and AM3-C57Bl/6 transgenic mice and Evaluation of in vivo mutagenicity of Sodium Dichromate Dihydrate
Genetic toxicity of sodium dichromate dihydrate in NTP peripheral blood micronucleus tests
Hexavalent Chromium Public Meeting - July 24, 2002
- Federal Register Notice
- Meeting Roster, Agenda and Staff Presentations (including public comments)
- Recommendations for the Proposed Studies of Hexavalent Chromium Carcinogenicity and Toxicokinetics Developed by the Expert Scientific Panel
Reproductive Studies of Hexavalent Chromium
- Reproductive Toxicity of Potassium Dichromate (Hexavalent) (CAS 7778-50-9) Administered in Diet to BALB/c Mice
- Reproductive Toxicity of Potassium Dichromate (Hexavalent) (CAS 7778-50-9) Administered in Diet to SD Rats
- Reproductive Toxicity (Testicular) of Potassium Dichromate (Hexavalent) (CAS 7778-50-9) Administered in Diet to BALB/c Mice
Current Status of the NTP Hexavalent Chromium Studies (Sodium Dichromate Dihydrate)
Web page last updated on September 26, 2007